Dianthus Therapeutics, Inc. (DNTH)
(Delayed Data from NSDQ)
$28.00 USD
+0.54 (1.97%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $27.98 -0.02 (-0.07%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.59 | 15.66% |
Earnings Summary
For their last quarter, Dianthus Therapeutics, Inc. (DNTH) reported earnings of -$0.51 per share, missing the Zacks Consensus Estimate of -$0.50 per share. This reflects a negative earnings surprise of 2.00%. Look out for DNTH's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.59 per share, reflecting a year-over-year increase of 84.39%.
Earnings History
Price & Consensus
Zacks News for DNTH
Dianthus (DNTH) Gains 18% in the Past Month: Here's Why
DNTH: What are Zacks experts saying now?
Zacks Private Portfolio Services